JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 17 No. 1 36-39
© 1976 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kubota, H.
Right arrow Articles by Reba, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kubota, H.
Right arrow Articles by Reba, R. C.

Technetium-99m-pyridoxylideneglutamate, a New Agent for Gallbladder Imaging: Comparison with 131I-rose Bengal

Haru Kubota, William C. Eckelman, Kattadiyll P. Poulose and Richard C. Reba

Washington Hospital Center and George Washington University, Washington, D.C.

Correspondence: For reprints contact: W. C. Eckelman, Nuclear Medicine Research, George Washington University, Walter G. Ross Hall—Room 225, Washington, D.C. 20037.

ABSTRACT

Two agents used for hepatobiliary studies, 131I-rose bengal and 99mTc-pyridoxylideneglutamate, have been compared in rabbits. The 99mTc radiopharmaceutical is rapidly cleared from the blood by the liver and rapidly excreted through the common bile duct into the duodenum. Because of its rapid removal from the liver, visualization of the gallbladder and biliary passages was obtained within 15 min after injection in experimental animals.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1976 by the Society of Nuclear Medicine.